Track topics on Twitter Track topics that are important to you
Aalto Scientific, Ltd was founded in 1979 in San Marcos, California to serve the needs of in vitro diagnostic reagent developers and manufacturers throughout the world. Aalto scientists pioneered the commercial purification of the HUMAN cardiac antigens, Creatine Kinase MM, MB and BB. The availability of these antigens enabled our customers to develop the first polyclonal, antibody-based assays to diagnose myocardial infarction.
The proliferation of EIA reagents created the need for other human antigens, as well as stable quality control materials, manufactured
with HUMAN sera and HUMAN proteins. In a natural progression of our existing technology, Aalto has become one of the leading OEM/Private label suppliers of quality control sera.
Today, Aalto Scientific, Ltd owns and operates it's own R&D and Manufacturing facility overlooking the Pacific Ocean in Carlsbad, CA, USA. In an industry that is unfortunately defined by constant corporate acquisition and divestiture, Aalto Scientific, Ltd is proud to be one of the few remaining privately owned and operated companies. As such, Aalto represents a stable, lasting presence in the diagnostic industry.
Please take a few moments to "tour our facility" and see how Aalto Scientific, Ltd
can solve your outsourcing problems efficiently and inexpensively .
1959 Kellogg Ave
United States of America
NewsQuantum physicist Mikko Möttönen and his team at Aalto University have invented a quantum-circuit refrigerator, which can reduce errors in quantum computing.Contribut
(VTT Technical Research Centre of Finland) VTT's small and lightweight hyperspectral camera was successfully launched to space in Aalto-1 nanosatellite on June 23, 2017. Scalable sensing technology of...
(Aalto University) according to scientists from Aalto University Finland, viruses and nanoparticles can be assembled into processable superlattice wires. The demonstration shows that electrostatic sel...
(Aalto University) Researchers at Aalto University, Finland, have developed anticancer nanomaterials by simulating the volcano-induced dynamic chemistry of the deep ocean. The novel method enables mak...
Life Sciences Jobs ...
Researchers at Aalto University, Finland, have developed anticancer nanomaterials by simulating the volcano-induced dynamic chemistry of the deep ocean.
NewsThe electronic properties of graphene can be controlled by synthesizing it into very narrow strips.Contributed Author:
NewsNew black phosphorous inks are compatible with conventional inkjet printing techniques for optoelectronics and photonics.Contributed Author:
SmileGuard Just 4 Me Kit
DESPIGMEN PROTECTIVE CREAM 25
Clarity and accuracy of reporting are fundamental to the scientific process. Readability formulas can estimate how difficult a text is to read. Here, in a corpus consisting of 709,577 abstracts publis...
The transmission of the scientific knowledge poses the question of the diversity of academic publications and stakeholders. Emphasis is placed on the relationship between scientific researchers and sc...
University scientific research ability is an important indicator to express the strength of universities. In this paper, the evaluation of university scientific research ability is investigated based ...
A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...
Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...
The intent of this protocol is to salvage human-related material that is normally destined for destruction, so it can be used in infection-related scientific studies.
Skin lesions, such as chronic ulcers and burns, represent a serious public health problem due to high government costs, and scarce successful conservative treatments.There is a growing sci...
The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialys...
AALTO SCIENTIFIC manufactures the world's finest HUMAN SERA to serve the needs of IN VITRO DIAGNOSTIC reagent developers and manufacturers throughout the world. In a natural progression of our existin...
Aalto Scientific, Ltd was founded in 1979 in San Marcos, California to serve the needs of in vitro diagnostic reagent developers and manufacturers throughout the world. Aalto scientists pioneered the ...
Aalto Bio Reagents supplies a broad range of purified human proteins; polyclonal antisera; purified monoclonal and polyclonal antibodies; fungal, protozoan, bacterial and viral antigens; and disease s...
Global Scientific Consulting is well qualified in the planning, design, development, and management of scientific projects; recruiting and teaching/training scientific researchers and technicians; wri...
Kent Scientific's President, Andrew Ide, founded Kent Scientific in 1989. Since then Kent Scientific has grown steadily each year. Kent has now become well known among research facilities including go...
We have published hundreds of Aalto Scientific, Ltd news stories on BioPortfolio along with dozens of Aalto Scientific, Ltd Clinical Trials and PubMed Articles about Aalto Scientific, Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aalto Scientific, Ltd Companies in our database. You can also find out about relevant Aalto Scientific, Ltd Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...